Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Cancers
|
September 28, 2021
Technical Challenges for CTC Implementation in Breast Cancer
Rocío Ramos-Medina, Sara López-Tarruella, María Del Monte-Millán, et al.
The Journal of Biological Chemistry
|
November 22, 2011
Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib
Juan Manuel Domínguez, Ana Fuertes, Leyre Orozco, et al.
Cancers
|
February 15, 2022
HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping
Coralia Bueno Muiño, Miguel Martín, María Del Monte-Millán, et al.
Journal of Molecular Neuroscience : MN
|
December 29, 2006
Dual binding site acetylcholinesterase inhibitors: potential new disease-modifying agents for AD
María del Monte-Millán, Esther García-Palomero, Rita Valenzuela, et al.
Frontiers in Oncology
|
October 12, 2020
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
Antonio Calles, María Inmaculada Aparicio, Manuel Alva, et al.
Breast Cancer Research and Treatment
|
December 5, 2025
Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HR + /HER2- advanced breast cancer after CDK4/6 inhibitor
Pablo Jara, Marc Ariant, Roberto Jiménez, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease
Pilar Muñoz-Ruiz, Laura Rubio, Esther García-Palomero, et al.
Journal of Natural Products
|
August 22, 2007
Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease
Mark Hamann, Diana Alonso, Ester Martín-Aparicio, et al.
BMC Psychiatry
|
December 21, 2022
A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH): study protocol
Raquel Lemos, Sofia Areias-Marques, Pedro Ferreira, et al.
JAMA Dermatology
|
August 7, 2020
Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer
Rocío Núñez-Torres, Miguel Martín, Jose Ángel García-Sáenz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Cancers
|
September 28, 2021
Technical Challenges for CTC Implementation in Breast Cancer
Rocío Ramos-Medina, Sara López-Tarruella, María Del Monte-Millán, et al.
The Journal of Biological Chemistry
|
November 22, 2011
Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib
Juan Manuel Domínguez, Ana Fuertes, Leyre Orozco, et al.
Cancers
|
February 15, 2022
HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping
Coralia Bueno Muiño, Miguel Martín, María Del Monte-Millán, et al.
Journal of Molecular Neuroscience : MN
|
December 29, 2006
Dual binding site acetylcholinesterase inhibitors: potential new disease-modifying agents for AD
María del Monte-Millán, Esther García-Palomero, Rita Valenzuela, et al.
Frontiers in Oncology
|
October 12, 2020
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
Antonio Calles, María Inmaculada Aparicio, Manuel Alva, et al.
Breast Cancer Research and Treatment
|
December 5, 2025
Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HR + /HER2- advanced breast cancer after CDK4/6 inhibitor
Pablo Jara, Marc Ariant, Roberto Jiménez, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease
Pilar Muñoz-Ruiz, Laura Rubio, Esther García-Palomero, et al.
Journal of Natural Products
|
August 22, 2007
Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease
Mark Hamann, Diana Alonso, Ester Martín-Aparicio, et al.
BMC Psychiatry
|
December 21, 2022
A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH): study protocol
Raquel Lemos, Sofia Areias-Marques, Pedro Ferreira, et al.
JAMA Dermatology
|
August 7, 2020
Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer
Rocío Núñez-Torres, Miguel Martín, Jose Ángel García-Sáenz, et al.
Page
of 2